Valink Therapeutics Inc.
About Valink Therapeutics Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Pre-A T: - FT: Pre-A |
A: 11800000 MR: - FA: 11.8 million FAN: 11800000 |
D: 2025-10-20 FD: 2025-10-20 |
6 investors |
Growth Metrics
Team & Leadership
Arne Scheu
CEO & Director
Irsyad Khairil
CTO & Director
Jose Munoz-Olaya
CSO
Nikitas Georgakopoulos
Principal Scientist
Ben Dorgan
Senior Scientist II
Inês Sá Pereira
Senior Scientist I
Recent News
Valink Therapeutics Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- valinktx.com
- Industries
- Biotechnology / Healthcare
- Company Size
- ~560 employees (est.)
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro